If additional studies yield similar results, relatively minor alterations in wild-type PTEN gene copy number might have prognostic and therapeutic implications for NSCLC patients in identifying a practical patient group likely to benefit from multi-targeted therapy. Here, PTEN is linked to non-small cell lung carcinoma.